MedTech Terms
    The authoritative reference
    All terms
    Market SegmentsStrategic Landscape

    Ophthalmology Devices

    Devices for diagnosis and treatment of eye conditions.

    Reviewed by Christian Espinosa, Founder, Blue Goat CyberLast reviewed May 5, 2026

    Definition

    Includes intraocular lenses (IOLs) for cataract surgery, refractive lasers (LASIK, SMILE), glaucoma implants (MIGS), retinal therapies (intravitreal delivery), and diagnostic OCT.
    What the regulation says
    Ophthalmology devices are regulated as medical devices by authorities such as the FDA in the United States and under the EU Medical Device Regulation (EU MDR) in Europe. The classification of these devices, as outlined in FDA 21 CFR Part 886 and EU MDR Annex VIII, depends on their intended use and risk, impacting the conformity assessment routes. For example, intraocular lenses are typically Class III devices in the US and Class IIb or III in Europe, requiring stringent pre-market review and clinical evidence.

    What this means in practice

    Alcon, J&J Vision, Bausch+Lomb, and Carl Zeiss Meditec are anchors. Premium IOLs (presbyopia-correcting) and MIGS are key growth drivers; reimbursement varies sharply between premium-channel cash pay and standard Medicare.

    Examples

    • A manufacturer of an intraocular lens (IOL) must submit a Premarket Approval (PMA) application to the FDA, including extensive clinical data on safety and effectiveness, per 21 CFR Part 814.
    • A company developing a new laser for LASIK surgery needs to ensure its software components comply with IEC 62304 for medical device software lifecycle processes and submit this to regulatory bodies.
    • An ophthalmic diagnostic device with AI-powered image analysis capabilities must demonstrate its algorithm's validity and reliability to meet performance standards.
    Common pitfalls
    • •Ophthalmology devices with novel technologies or higher risks, like some implantable devices, often require extensive clinical data before market approval, a common pitfall for manufacturers.
    • •Misinterpreting device classification rules can lead to incorrect regulatory pathways, causing significant delays in market access.
    • •Failing to adequately address cybersecurity risks for connected ophthalmology devices can result in non-compliance with regulations such as those outlined in FDA premarket submissions for cybersecurity.
    • •Not aligning with international standards for quality management systems, such as ISO 13485, can create compliance challenges across different markets.

    Frequently asked questions

    The primary concern is often long-term safety and performance, necessitating robust clinical data and post-market surveillance plans, as per EU MDR Article 83 and FDA 21 CFR Part 822.
    Grouped by theme

    Primary references

    3 sources
    Link health: 3 verified· last checked 2026-06-20
    AAO·1MedTech Europe·1MedTech Dive·1
    1. 1
      AAO
      Verified
      AAOaao.org
    2. 2
      MedTech Europe - Facts & Figures
      Verified
      MedTech Europemedtecheurope.org
    3. 3
      MedTech Dive
      Verified
      MedTech Divemedtechdive.com

    Inline markers like [1] jump to the matching reference above.